Navigate to
-
A roundup of Prime's award-winning presentations and insights at AMCP 2026 in Nashville, Tennessee
-
Managed Healthcare Executive
PA Sub-Categories: GLP-1 Prime Article: In the News -
USA Today
PA Sub-Categories: GLP-1 Prime Article: In the News -
Reuters
PA Sub-Categories: GLP-1 Prime Article: In the News -
Insider
PA Sub-Categories: GLP-1 Prime Article: In the News -
CNBC
PA Sub-Categories: GLP-1 Prime Article: In the News -
Formulary Watch
PA Sub-Categories: GLP-1 Prime Article: In the News -
Star Tribune
PA Sub-Categories: GLP-1 Prime Article: In the News -
Business Insider
PA Sub-Categories: GLP-1 Prime Article: In the News -
Endpoint News
PA Sub-Categories: GLP-1 Prime Article: In the News -
Reuters
PA Sub-Categories: GLP-1 Prime Article: In the News -
Washington Post: Doctors and patients struggle with starting and stopping medications with little guidance.
PA Sub-Categories: GLP-1 Prime Article: In the News -
Reuters
PA Sub-Categories: GLP-1 Prime Article: In the News -
Reuters
PA Sub-Categories: GLP-1 Prime Article: In the News -
NBC News: Patients weren't asked why they quit taking the weight loss drugs
PA Sub-Categories: GLP-1 Prime Article: In the News -
Reuters
PA Sub-Categories: GLP-1 Prime Article: In the News -
Prime Therapeutics’ Clinical Insights is your trusted resource for timely, evidence based perspectives on emerging therapies and managed care strategy. The Summer 2025 issue focuses on metabolic...
-
Novartis submitted an application to the FDA in 2Q 2025 for an intrathecal formulation (OAV101IT) of their one-time gene therapy onasemnogene abeparvovec (OAV101IT) for the treatment of spinal...
-
Hear some of the latest insights from the annual managed care pharmacy event, where Prime Therapeutics clinical and health outcomes teams presented leading research findings
PA Sub-Categories: Awards GLP-1 Specialty drugs Prime Article: Stories -
Maryam Tabatabai, PharmD, associate vice president of clinical information, shares more about how cell and gene therapies are transforming the treatment landscape, and how payers and providers can...
PA Sub-Categories: Specialty drugs Prime Article: Stories